Bezlotoxumab<\/b>, sold under the brand name\u00a0Zinplava<\/b>, is a human monoclonal antibody designed for the prevention of recurrence of Clostridioides difficile infections. Bezlotoxumab is indicated to reduce recurrence of Clostridioides difficile infection in people who are receiving antibacterial drug treatment for Clostridioides difficile infection and are at a high risk for Clostridioides difficile infection recurrence.<\/p>\n
ZINPLAVA 25 mg\/mL concentrate for solution for infusion<\/strong><\/p>\n ZINPLAVA (bezlotoxumab) may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n Named-patient import facilitator contact details<\/strong> Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n NEWS\/UPDATES<\/p>\n Note:<\/strong><\/em> ZINPLAVA is a human monoclonal antibody that binds to Clostridioides difficile toxin B, indicated to reduce recurrence of Clostridioides difficile infection (CDI) in adults and pediatric patients 1 year of age and olderIs ZINPLAVA (bezlotoxumab) available in India?<\/h4>\n
How to get ZINPLAVA injection delivered in India?<\/h4>\n
Who can help source ZINPLAVA injection in India legally?<\/h4>\n
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"ZINPLAVA (bezlotoxumab) \u2013 Antibacterial drug Therapy in India<\/h2>\n
\nwho are receiving antibacterial drug treatment for CDI and are at a high risk for CDI recurrence.<\/p>\n\n\n
\n Brand Name:<\/strong><\/td>\n ZINPLAVA<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n bezlotoxumab injection<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 Injection: 1,000 mg\/40 mL (25 mg\/mL) solution in a single-dose vial.<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n Merck Sharp & Dohme LLC<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n